SC 13D

Company

Arbutus Biopharma Corp

Filed

July 13, 2016

Accession Number

0001104659-16-132418

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →